ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

BSGM BioSig Technologies Inc

1.32
0.02 (1.54%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioSig Technologies Inc BSGM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.02 1.54% 1.32 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.31 1.2701 1.39 1.37 1.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/4/202410:35GLOBEBioSig Engages Consulting Firm for Business Model Strategies
11/3/202408:00EDGAR2Form 8-K - Current report
04/3/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202408:00EDGAR2Form 8-K - Current report
20/2/202409:00GLOBEBioSig Announces Reduction of its Workforce
14/2/202414:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202407:35EDGAR2Form 8-K - Current report
06/2/202407:30GLOBEBioSig’s PURE EP™ Platform with New Near Field Tracking..
02/2/202416:18EDGAR2Form 8-K/A - Current report: [Amend]
01/2/202416:25EDGAR2Form 8-K - Current report
31/1/202415:05EDGAR2Form 8-K - Current report
31/1/202410:15GLOBEBioSig Announces Reverse Stock Split
30/1/202407:52EDGAR2Form 8-K - Current report
30/1/202407:30GLOBEBioSig Announces Cost Reductions to Improve its Financial..
16/1/202415:15EDGAR2Form D - Notice of Exempt Offering of Securities
12/1/202416:28EDGAR2Form 8-K - Current report
08/1/202410:00EDGAR2Form 8-K - Current report
05/1/202415:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202312:37EDGAR2Form DEL AM - Delaying amendment
28/12/202315:30EDGAR2Form 8-K - Current report
28/12/202315:05EDGAR2Form S-3 - Registration statement under Securities Act of..
22/12/202315:30EDGAR2Form 8-K - Current report
18/12/202315:36EDGAR2Form 8-K - Current report
06/12/202316:07EDGAR2Form 8-K - Current report
06/12/202313:20GLOBEBioSig Issues Letter to Shareholders Detailing Technology..
05/12/202316:29EDGAR2Form 8-K - Current report
04/12/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202308:13EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202316:32EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202316:02EDGAR2Form 8-K - Current report
13/11/202315:30GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
13/11/202307:35EDGAR2Form 8-K - Current report
09/11/202307:00GLOBEBioSig Announces $2.5 Million Registered Direct Offering..
08/11/202315:05EDGAR2Form 8-K - Current report
07/11/202307:01EDGAR2Form 8-K - Current report
07/11/202307:00GLOBEBioSig Appoints Global MedTech Leader Fred Hrkac as New..
03/11/202315:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202315:30EDGAR2Form DEF 14A - Other definitive proxy statements
02/11/202307:00EDGAR2Form 8-K - Current report
02/11/202307:00GLOBEBioSig’s New PURE EP™ Subscription Model Adopted by Mayo..
02/11/202306:17EDGAR2Form 8-K - Current report
01/11/202307:35EDGAR2Form 8-K - Current report
01/11/202307:30GLOBEBioSig Adds Five New Patent Awards to 100+ Total Patent..
24/10/202315:30EDGAR2Form PRE 14A - Other preliminary proxy statements
16/10/202316:00EDGAR2Form 8-K - Current report
27/9/202316:01EDGAR2Form 8-K - Current report
15/9/202315:54EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock